— Know what they know.
Not Investment Advice

CERS NASDAQ

Cerus Corporation
1W: +9.2% 1M: +41.2% 3M: +13.7% YTD: +39.1% 1Y: +104.5% 3Y: +45.7% 5Y: -52.4%
$2.71
-0.03 (-1.09%)
 
Weekly Expected Move ±18.8%
$1 $2 $2 $3 $3
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Strong Buy · Power 69 · $543.0M mcap · 190M float · 1.19% daily turnover · Short 43% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
53.6 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: -10.1%  ·  5Y Avg: -56.7%
Cost Advantage ★
72
Intangibles
38
Switching Cost
63
Network Effect
58
Scale
35
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CERS shows a Weak competitive edge (53.6/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. Negative ROIC of -10.1% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$4
Low
$4
Avg Target
$4
High
Based on 1 analyst since Apr 30, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 8Hold: 2Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$4.00
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-01 BTIG Initiated $4 +97.0% $2.03
2024-10-17 Stifel Nicolaus Mathew Blackman Initiated $3 +66.7% $1.80
2024-05-03 Cantor Fitzgerald Brandon Folkes Initiated $4 +127.3% $1.76
2024-04-12 Craig-Hallum Bill Bonello Initiated $5 +179.3% $1.79

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
May 22, 2026
DCF
5
ROE
1
ROA
1
D/E
1
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CERS receives an overall rating of C. Strongest factors: DCF (5/5). Areas of concern: ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-03-03 C- C
2026-03-02 C C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

27 Grade D
Profitability
17
Balance Sheet
50
Earnings Quality
57
Growth
84
Value
17
Momentum
77
Safety
0
Cash Flow
12
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CERS scores highest in Growth (84/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-4.20
Distress Zone
Piotroski F-Score
5/9
Beneish M-Score
-2.63
Unlikely Manipulator
Ohlson O-Score
-5.12
Bankruptcy prob: 0.6%
Low Risk
Credit Rating
B-
Score: 22.3/100
Trend: Deteriorating
Earnings Quality
OCF/NI: -0.28x
Accruals: -5.8%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CERS scores -4.20, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CERS scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CERS's score of -2.63 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CERS's implied 0.6% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CERS receives an estimated rating of B- (score: 22.3/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-55.09x
PEG
-0.87x
P/S
2.44x
P/B
7.79x
P/FCF
-290.10x
P/OCF
134.25x
EV/EBITDA
-53.66x
EV/Revenue
1.65x
EV/EBIT
-40.25x
EV/FCF
-301.65x
Earnings Yield
-2.70%
FCF Yield
-0.34%
Shareholder Yield
0.07%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. CERS currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.038
NI / EBT
×
Interest Burden
1.007
EBT / EBIT
×
EBIT Margin
-0.041
EBIT / Rev
×
Asset Turnover
1.054
Rev / Assets
×
Equity Multiplier
3.512
Assets / Equity
=
ROE
-15.9%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CERS's ROE of -15.9% is driven by financial leverage (equity multiplier: 3.51x). Note: high leverage means ROE is amplified by debt rather than operational performance. A tax burden ratio of 1.04 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$2.71
Median 1Y
$1.94
5th Pctile
$0.68
95th Pctile
$5.59
Ann. Volatility
66.3%
Analyst Target
$4.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
William M. Greenman
President and Chief Executive Officer
$793,750 $2,242,585 $3,794,657
Vivek Jayaraman
Chief Operating Officer
$565,768 $1,240,044 $2,204,198
Kevin D. Green
Chief Financial Officer
$507,440 $918,826 $1,750,398
Chrystal Jensen
Chief Legal Officer, General Counsel and Secretary
$487,076 $866,753 $1,622,257
Richard Benjamin
Chief Medical Officer
$508,690 $713,844 $1,506,553

CEO Pay Ratio

13:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $3,794,657
Avg Employee Cost (SGA/emp): $294,233
Employees: 275

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
275
-2.1% YoY
Revenue / Employee
$749,575
Rev: $206,133,000
Profit / Employee
$-56,825
NI: $-15,627,000
SGA / Employee
$294,233
Avg labor cost proxy
R&D / Employee
$246,255
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -76.3% -74.1% -57.7% -52.2% -44.8% -40.6% -56.2% -60.6% -67.0% -65.4% -62.3% -52.5% -40.0% -32.8% -38.5% -34.8% -34.7% -29.3% -26.0% -15.9% -15.87%
ROA -31.7% -30.8% -23.7% -21.4% -18.4% -16.7% -18.8% -20.2% -22.4% -21.9% -18.0% -15.2% -11.6% -9.5% -10.5% -9.5% -9.5% -8.0% -7.4% -4.5% -4.52%
ROIC -1.3% -1.2% -90.2% -78.1% -64.1% -57.3% -51.1% -57.5% -64.7% -61.4% -28.7% -22.8% -15.3% -11.3% -15.2% -13.0% -12.5% -10.2% -15.6% -10.1% -10.10%
ROCE -35.2% -33.9% -30.9% -27.4% -23.0% -20.5% -36.1% -39.2% -43.3% -41.1% -22.2% -17.2% -11.4% -8.1% -8.7% -7.3% -7.3% -5.3% -11.8% -7.5% -7.54%
Gross Margin 51.3% 51.3% 51.1% 51.7% 51.9% 55.4% 55.7% 55.8% 54.9% 54.9% 55.5% 55.4% 54.7% 56.9% 53.9% 58.8% 55.2% 53.4% 51.5% 57.0% 56.98%
Operating Margin -45.7% -30.8% -17.5% -26.3% -16.7% -18.8% -22.6% -45.7% -30.0% -13.2% 2.1% -20.8% -8.5% -2.1% -2.9% -13.5% -6.5% 2.3% -12.9% -0.6% -0.59%
Net Margin -48.8% -34.4% -22.9% -32.8% -20.5% -21.4% -30.9% -50.4% -34.2% -18.3% -2.8% -25.3% -12.8% -6.4% -5.0% -17.8% -10.9% -0.0% -3.8% -2.7% -2.74%
EBITDA Margin -41.8% -28.6% -17.3% -26.6% -15.1% -16.0% -25.0% -43.0% -26.8% -10.5% 3.3% -17.6% -6.7% -0.4% -0.1% -12.1% -6.0% 4.9% -11.0% 0.2% 0.16%
FCF Margin -37.7% -34.9% -26.2% -26.4% -19.7% -16.7% -17.0% -10.3% -16.4% -23.3% -30.5% -22.5% -15.9% -5.9% 4.7% 3.6% 1.8% 0.1% 0.5% -0.5% -0.55%
OCF Margin -36.8% -34.1% -25.5% -25.8% -19.2% -15.9% -15.8% -8.1% -13.9% -19.5% -27.6% -20.0% -13.7% -4.9% 6.3% 4.6% 3.0% 1.8% 2.3% 1.2% 1.18%
ROE 3Y Avg snapshot only -36.19%
ROE 5Y Avg snapshot only -46.98%
ROA 3Y Avg snapshot only -9.90%
ROIC 3Y Avg snapshot only -33.03%
ROIC Economic snapshot only -5.05%
Cash ROA snapshot only 1.19%
Cash ROIC snapshot only 3.36%
CROIC snapshot only -1.56%
NOPAT Margin snapshot only -3.55%
Pretax Margin snapshot only -4.13%
R&D / Revenue snapshot only 29.47%
SGA / Revenue snapshot only 36.17%
SBC / Revenue snapshot only 9.49%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -16.50 -17.55 -21.68 -19.47 -22.17 -16.67 -15.14 -11.48 -8.71 -5.89 -10.44 -10.91 -13.53 -16.36 -13.59 -13.72 -14.29 -19.11 -25.32 -37.00 -55.092
P/S Ratio 9.49 8.78 9.01 6.61 6.06 4.04 4.00 3.40 2.90 1.91 2.50 2.10 1.92 1.83 1.58 1.40 1.40 1.53 1.92 1.59 2.437
P/B Ratio 9.75 10.09 13.93 11.32 11.06 7.54 9.58 7.83 6.57 4.34 7.43 6.54 6.18 6.13 5.06 4.63 4.80 5.43 6.16 5.50 7.788
P/FCF -25.19 -25.20 -34.36 -25.05 -30.71 -24.25 -23.46 -32.95 -17.71 -8.20 -8.19 -9.33 -12.02 -30.90 33.35 38.77 78.80 1815.53 357.17 -290.10 -290.097
P/OCF 25.02 30.39 47.25 85.53 81.82 134.25 134.247
EV/EBITDA -17.63 -18.99 -24.73 -22.70 -26.78 -20.27 -18.88 -13.95 -10.45 -7.15 -16.01 -18.93 -28.73 -42.00 -30.11 -32.67 -33.32 -54.95 -33.68 -53.66 -53.659
EV/Revenue 8.86 8.22 8.69 6.32 5.79 3.78 3.91 3.31 2.80 1.81 2.70 2.29 2.09 2.00 1.67 1.50 1.49 1.62 1.99 1.65 1.649
EV/EBIT -16.64 -17.90 -23.14 -21.02 -24.43 -18.31 -17.34 -12.98 -9.82 -6.70 -14.57 -16.74 -24.01 -33.38 -25.41 -27.68 -28.68 -44.58 -28.64 -40.25 -40.250
EV/FCF -23.53 -23.59 -33.14 -23.96 -29.34 -22.66 -22.92 -32.02 -17.12 -7.78 -8.83 -10.15 -13.14 -33.79 35.42 41.41 83.96 1920.56 369.87 -301.65 -301.647
Earnings Yield -6.1% -5.7% -4.6% -5.1% -4.5% -6.0% -6.6% -8.7% -11.5% -17.0% -9.6% -9.2% -7.4% -6.1% -7.4% -7.3% -7.0% -5.2% -3.9% -2.7% -2.70%
FCF Yield -4.0% -4.0% -2.9% -4.0% -3.3% -4.1% -4.3% -3.0% -5.6% -12.2% -12.2% -10.7% -8.3% -3.2% 3.0% 2.6% 1.3% 0.1% 0.3% -0.3% -0.34%
Price/Tangible Book snapshot only 5.617
EV/OCF snapshot only 139.592
EV/Gross Profit snapshot only 3.037
Shareholder Yield snapshot only 0.07%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 3.06 3.06 2.38 2.38 2.38 2.38 1.45 1.45 1.45 1.45 2.14 2.14 2.14 2.14 2.39 2.39 2.39 2.39 1.73 1.73 1.730
Quick Ratio 2.67 2.67 2.04 2.04 2.04 2.04 1.21 1.21 1.21 1.21 1.55 1.55 1.55 1.55 1.79 1.79 1.79 1.79 1.17 1.17 1.173
Debt/Equity 0.64 0.64 1.04 1.04 1.04 1.04 1.29 1.29 1.29 1.29 1.82 1.82 1.82 1.82 1.75 1.75 1.75 1.75 1.51 1.51 1.509
Net Debt/Equity -0.64 -0.64 -0.49 -0.49 -0.49 -0.49 -0.22 -0.22 -0.22 -0.22 0.57 0.57 0.57 0.57 0.31 0.31 0.31 0.31 0.22 0.22 0.219
Debt/Assets 0.30 0.30 0.37 0.37 0.37 0.37 0.40 0.40 0.40 0.40 0.49 0.49 0.49 0.49 0.49 0.49 0.49 0.49 0.44 0.44 0.437
Debt/EBITDA -1.25 -1.30 -1.90 -2.17 -2.62 -2.98 -2.60 -2.37 -2.12 -2.24 -3.65 -4.86 -7.75 -11.43 -9.79 -11.54 -11.37 -16.71 -7.97 -14.16 -14.159
Net Debt/EBITDA 1.24 1.29 0.91 1.04 1.25 1.42 0.44 0.40 0.36 0.38 -1.14 -1.52 -2.44 -3.59 -1.76 -2.08 -2.05 -3.00 -1.16 -2.05 -2.054
Interest Coverage -13.55 -12.06 -9.98 -8.17 -6.85 -5.95 -6.26 -6.54 -6.34 -5.29 -3.45 -2.48 -1.62 -1.17 -1.34 -1.15 -1.17 -0.86 -1.71 -1.13 -1.126
Equity Multiplier 2.13 2.13 2.81 2.81 2.81 2.81 3.23 3.23 3.23 3.23 3.76 3.76 3.76 3.76 3.58 3.58 3.58 3.58 3.45 3.45 3.454
Cash Ratio snapshot only 0.822
Debt Service Coverage snapshot only -0.845
Cash to Debt snapshot only 0.855
FCF to Debt snapshot only -0.013
Defensive Interval snapshot only 315.6 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.55 0.62 0.57 0.63 0.67 0.69 0.71 0.68 0.67 0.67 0.75 0.79 0.82 0.85 0.90 0.93 0.97 1.00 0.98 1.05 1.054
Inventory Turnover 2.32 2.63 2.54 2.82 2.99 2.99 2.69 2.53 2.45 2.46 2.03 2.13 2.21 2.27 2.07 2.09 2.17 2.29 1.99 2.16 2.160
Receivables Turnover 5.61 6.27 5.65 6.26 6.67 6.82 5.44 5.22 5.15 5.16 4.47 4.68 4.86 5.04 5.52 5.67 5.90 6.10 6.85 7.41 7.408
Payables Turnover 2.14 2.42 2.12 2.36 2.50 2.51 2.18 2.06 1.99 2.00 2.46 2.58 2.68 2.75 3.55 3.58 3.71 3.92 3.78 4.10 4.096
DSO 65 58 65 58 55 54 67 70 71 71 82 78 75 72 66 64 62 60 53 49 49.3 days
DIO 157 139 144 130 122 122 136 144 149 148 180 171 165 161 176 175 168 160 183 169 169.0 days
DPO 171 151 172 155 146 146 167 177 183 182 148 141 136 133 103 102 98 93 97 89 89.1 days
Cash Conversion Cycle 52 46 36 33 31 30 36 37 37 37 113 108 104 101 139 137 132 126 140 129 129.1 days
Fixed Asset Turnover snapshot only 11.527
Operating Cycle snapshot only 218.2 days
Cash Velocity snapshot only 2.688
Capital Intensity snapshot only 0.996
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 34.9% 40.8% 42.4% 49.9% 44.8% 32.5% 23.8% 7.4% -0.7% -2.7% -3.5% 5.3% 10.8% 14.7% 15.3% 13.1% 13.3% 13.0% 14.3% 20.3% 20.33%
Net Income 7.4% 4.4% 9.2% 19.1% 31.2% 35.8% 21.3% 6.3% -20.8% -30.1% 12.4% 31.6% 52.8% 60.4% 44.2% 40.0% 21.5% 19.1% 25.3% 49.6% 49.60%
EPS 11.1% 7.4% 12.2% 21.8% 33.4% 37.8% 23.3% 8.3% -18.3% -27.4% 14.2% 33.0% 53.9% 61.3% 45.2% 41.6% 24.1% 21.8% 28.2% 51.4% 51.43%
FCF 34.9% 3.3% 20.0% 5.0% 24.1% 36.7% 19.5% 58.0% 17.7% -35.9% -73.0% -1.3% -7.9% 70.8% 1.2% 1.2% 1.1% 1.0% -87.0% -1.2% -1.18%
EBITDA 9.7% 6.9% 12.8% 24.6% 37.7% 43.0% 27.1% 8.6% -23.0% -32.3% 21.4% 46.4% 69.9% 78.4% 61.9% 57.0% 30.3% 30.1% -21.4% 19.4% 19.45%
Op. Income 6.6% 6.8% 16.1% 28.7% 41.2% 44.8% 30.4% 9.3% -24.2% -31.8% 11.8% 37.8% 62.8% 71.2% 52.7% 49.3% 27.3% 19.6% -9.0% 17.3% 17.27%
OCF Growth snapshot only -69.24%
Asset Growth snapshot only 10.42%
Equity Growth snapshot only 14.39%
Debt Growth snapshot only -1.17%
Shares Change snapshot only 3.78%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 23.9% 25.3% 29.0% 30.7% 31.7% 31.0% 29.5% 27.1% 24.7% 22.0% 19.4% 19.2% 16.8% 13.9% 11.3% 8.5% 7.6% 8.1% 8.4% 12.7% 12.71%
Revenue 5Y 25.3% 26.6% 28.6% 31.7% 33.2% 33.3% 30.0% 25.4% 22.3% 20.4% 20.8% 20.4% 20.2% 20.2% 19.3% 19.6% 19.5% 18.7% 17.5% 18.2% 18.17%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 29.2% 30.6% 32.0% 32.4% 32.1% 30.1% 28.3% 26.0% 24.4% 22.4% 19.4% 19.7% 17.9% 15.9% 13.9% 11.7% 10.7% 9.8% 8.8% 12.5% 12.48%
Gross Profit 5Y 33.2% 31.8% 31.9% 34.6% 35.0% 35.1% 32.9% 28.8% 26.3% 24.6% 24.2% 23.0% 22.1% 21.1% 19.3% 19.6% 19.6% 18.8% 17.2% 18.1% 18.06%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 31.1% 31.1% 13.3% 13.3% 13.3% 13.3% 9.6% 9.6% 9.6% 9.6% -3.7% -3.7% -3.7% -3.7% -5.4% -5.4% -5.4% -5.4% 0.6% 0.6% 0.57%
Assets 5Y 9.7% 9.7% 18.1% 18.1% 18.1% 18.1% 17.3% 17.3% 17.3% 17.3% 3.9% 3.9% 3.9% 3.9% 4.0% 4.0% 4.0% 4.0% 0.0% 0.0% 0.04%
Equity 3Y 38.7% 38.7% 0.0% 0.0% 0.0% 0.0% 5.8% 5.8% 5.8% 5.8% -20.3% -20.3% -20.3% -20.3% -12.8% -12.8% -12.8% -12.8% -1.7% -1.7% -1.70%
Book Value 3Y 26.9% 27.7% -7.7% -7.7% -7.9% -7.3% -1.5% 1.5% 2.6% 2.9% -22.3% -22.2% -22.3% -22.2% -14.6% -14.8% -15.0% -15.1% -4.3% -4.5% -4.45%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.95 0.93 0.92 0.90 0.91 0.95 0.95 0.94 0.92 0.92 0.93 0.94 0.93 0.94 0.92 0.93 0.91 0.92 0.93 0.97 0.973
Earnings Stability 0.00 0.00 0.08 0.18 0.19 0.28 0.40 0.36 0.21 0.30 0.70 0.85 0.80 0.81 0.98 0.98 0.88 0.84 0.98 0.98 0.982
Margin Stability 0.87 0.90 0.91 0.92 0.94 0.96 0.94 0.94 0.93 0.93 0.94 0.95 0.96 0.97 0.97 0.96 0.97 0.98 0.99 0.99 0.988
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 1.00 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 1.00 1.00 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0
Earnings Persistence 0.97 0.98 0.96 0.92 0.88 0.86 0.91 0.97 0.92 0.88 0.95 0.87 0.50 0.50 0.82 0.84 0.91 0.92 0.90 0.80 0.802
Earnings Smoothness
ROE Trend 0.38 0.39 0.27 0.32 0.38 0.38 -0.02 -0.10 -0.21 -0.22 -0.07 0.03 0.17 0.22 0.30 0.30 0.27 0.27 0.30 0.32 0.320
Gross Margin Trend 0.00 -0.01 -0.04 -0.04 -0.03 -0.01 0.00 0.02 0.03 0.03 0.03 0.02 0.02 0.02 0.01 0.01 0.01 -0.00 -0.01 -0.01 -0.013
FCF Margin Trend 0.42 0.43 0.47 0.40 0.38 0.26 0.19 0.24 0.12 0.02 -0.09 -0.04 0.02 0.14 0.29 0.20 0.18 0.15 0.13 0.09 0.089
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.64 0.68 0.61 0.76 0.70 0.66 0.60 0.27 0.42 0.60 1.15 1.04 0.97 0.44 -0.54 -0.45 -0.30 -0.22 -0.31 -0.28 -0.276
FCF/OCF 1.02 1.02 1.03 1.02 1.03 1.05 1.08 1.27 1.18 1.20 1.11 1.13 1.16 1.22 0.75 0.78 0.60 0.05 0.23 -0.46 -0.463
FCF/Net Income snapshot only 0.128
CapEx/Revenue 0.9% 0.8% 0.7% 0.6% 0.6% 0.8% 1.2% 2.2% 2.5% 3.8% 2.9% 2.5% 2.2% 1.1% 1.6% 1.0% 1.2% 1.7% 1.8% 1.7% 1.73%
CapEx/Depreciation snapshot only 1.688
Accruals Ratio -0.11 -0.10 -0.09 -0.05 -0.06 -0.06 -0.08 -0.15 -0.13 -0.09 0.03 0.01 -0.00 -0.05 -0.16 -0.14 -0.12 -0.10 -0.10 -0.06 -0.058
Sloan Accruals snapshot only -0.081
Cash Flow Adequacy snapshot only 0.684
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0%
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.07%
Net Buyback Yield 0.0% 0.0% -0.6% -0.8% -0.8% -1.2% 0.0% -0.1% -0.1% -0.3% -0.2% -0.2% -0.2% -0.1% -0.1% -0.0% -0.0% -0.1% 0.0% 0.1% 0.07%
Total Shareholder Return 0.0% 0.0% -0.6% -0.8% -0.8% -1.2% 0.0% -0.1% -0.1% -0.3% -0.2% -0.2% -0.2% -0.1% -0.1% -0.0% -0.0% -0.1% 0.0% 0.1% 0.07%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.00 1.01 1.00 1.01 1.01 1.01 1.02 1.02 1.02 1.04 1.038
Interest Burden (EBT/EBIT) 1.07 1.08 1.10 1.12 1.15 1.17 1.16 1.15 1.16 1.19 1.29 1.40 1.62 1.86 1.75 1.87 1.86 2.17 1.07 1.01 1.007
EBIT Margin -0.53 -0.46 -0.38 -0.30 -0.24 -0.21 -0.23 -0.25 -0.28 -0.27 -0.19 -0.14 -0.09 -0.06 -0.07 -0.05 -0.05 -0.04 -0.07 -0.04 -0.041
Asset Turnover 0.55 0.62 0.57 0.63 0.67 0.69 0.71 0.68 0.67 0.67 0.75 0.79 0.82 0.85 0.90 0.93 0.97 1.00 0.98 1.05 1.054
Equity Multiplier 2.41 2.41 2.44 2.44 2.44 2.44 2.99 2.99 2.99 2.99 3.46 3.46 3.46 3.46 3.66 3.66 3.66 3.66 3.51 3.51 3.512
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-0.36 $-0.35 $-0.31 $-0.28 $-0.24 $-0.22 $-0.24 $-0.26 $-0.28 $-0.28 $-0.21 $-0.17 $-0.13 $-0.11 $-0.11 $-0.10 $-0.10 $-0.08 $-0.08 $-0.05 $-0.05
Book Value/Share $0.61 $0.60 $0.49 $0.48 $0.48 $0.48 $0.38 $0.38 $0.37 $0.37 $0.29 $0.29 $0.28 $0.28 $0.30 $0.30 $0.29 $0.29 $0.33 $0.33 $0.35
Tangible Book/Share $0.60 $0.60 $0.48 $0.48 $0.47 $0.47 $0.37 $0.37 $0.37 $0.37 $0.28 $0.28 $0.28 $0.28 $0.30 $0.29 $0.29 $0.29 $0.33 $0.32 $0.32
Revenue/Share $0.62 $0.69 $0.76 $0.83 $0.87 $0.89 $0.91 $0.87 $0.85 $0.85 $0.86 $0.90 $0.92 $0.95 $0.98 $0.99 $1.01 $1.04 $1.07 $1.15 $1.15
FCF/Share $-0.23 $-0.24 $-0.20 $-0.22 $-0.17 $-0.15 $-0.16 $-0.09 $-0.14 $-0.20 $-0.26 $-0.20 $-0.15 $-0.06 $0.05 $0.04 $0.02 $0.00 $0.01 $-0.01 $-0.01
OCF/Share $-0.23 $-0.24 $-0.19 $-0.21 $-0.17 $-0.14 $-0.14 $-0.07 $-0.12 $-0.17 $-0.24 $-0.18 $-0.13 $-0.05 $0.06 $0.05 $0.03 $0.02 $0.03 $0.01 $0.01
Cash/Share $0.78 $0.78 $0.75 $0.74 $0.73 $0.73 $0.58 $0.57 $0.57 $0.56 $0.36 $0.36 $0.36 $0.36 $0.44 $0.43 $0.42 $0.42 $0.43 $0.43 $0.41
EBITDA/Share $-0.31 $-0.30 $-0.27 $-0.23 $-0.19 $-0.17 $-0.19 $-0.21 $-0.23 $-0.22 $-0.15 $-0.11 $-0.07 $-0.05 $-0.05 $-0.05 $-0.05 $-0.03 $-0.06 $-0.04 $-0.04
Debt/Share $0.39 $0.39 $0.51 $0.50 $0.49 $0.49 $0.49 $0.49 $0.48 $0.48 $0.53 $0.53 $0.52 $0.52 $0.53 $0.52 $0.51 $0.51 $0.50 $0.50 $0.50
Net Debt/Share $-0.39 $-0.39 $-0.24 $-0.24 $-0.24 $-0.24 $-0.08 $-0.08 $-0.08 $-0.08 $0.17 $0.17 $0.16 $0.16 $0.10 $0.09 $0.09 $0.09 $0.07 $0.07 $0.07
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score -4.205
Altman Z-Prime snapshot only -11.623
Piotroski F-Score 5 5 4 4 5 5 4 4 3 2 3 3 4 5 6 7 7 6 5 5 5
Beneish M-Score -2.53 -2.45 -2.10 -1.87 -2.02 -2.12 -2.58 -2.84 -2.81 -2.54 -2.08 -2.17 -2.24 -2.53 -3.36 -3.27 -3.17 -3.01 -2.92 -2.63 -2.634
Ohlson O-Score snapshot only -5.123
ROIC (Greenblatt) snapshot only -9.82%
Net-Net WC snapshot only $0.09
EVA snapshot only $-15737000.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only B-
Credit Score 28.63 28.38 24.76 25.13 25.31 25.60 22.29 22.12 22.31 22.43 25.19 25.20 25.05 24.65 28.37 27.38 26.28 26.05 23.56 22.32 22.317
Credit Grade snapshot only 16
Credit Trend snapshot only -5.063
Implied Spread (bps) snapshot only 900.000
Industry Credit Rank snapshot only 10
Sector Credit Rank snapshot only 10

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms